Report Details:
15 Companies Covered
110 Pages
Pune, India, July 13, 2025/MRFR Press Release/- Market research future published a Half cooked research report on Global Transgenic animals Market.
The Transgenic Animals Market is expected to reach USD 7.65 billion by 2032 at 11.67% CAGR during the forecast period 2024 - 2032.
Global Transgenic Animals Market Highlights
Transgenic animals have a deliberately altered genetic make-up and are extensively exploited in the veterinary, medical sciences, and research sectors. The Americas leads the global transgenic animals market due to increasing prevalence of diabetes and cardiovascular disorders, growing biotechnology sector, and rising acceptance of transgenic products. Additionally, the presence of the market’s key players like Charles River, Cyagen Biosciences, and others within the region fuels the market growth. However, high cost and stringent FDA approval policies may restrain the market growth within the region.
On the regional basis, the Americas transgenic animals market is segmented into the two major regions, i.e., North America and South America. North America dominates the Americas transgenic animals market due to the presence of developed economies like the U.S. and Canada within the region. However, the South America segment is showing the fastest growth in the market due to the presence of huge opportunities for the development of the market.
The Americas transgenic animals market is segmented on the basis of product, techniques, consumables, application, model organism, and end-user.
On the basis of the product, the market is categorized into PCR, gene gun, microinjections, electroporator, and others. The PCR segment is sub segmented into real time PCR, digital PCR systems, and others. On the basis of the techniques, the market is segmented into retrovirus-mediated gene transfer, embryonic stem cell-mediated gene transfer, DNA microinjection, and others. On the basis of the consumables, the market is segmented into fluorescent probes, culture media, and others. On the basis of the application, the market is segmented into recombinant human proteins, monoclonal antibodies, xenotransplantation, and others. On the basis of the model organism, the market is segmented into mice, rabbit, cows, and others. On the basis of the end-user, the market is segmented into biotechnology industries, research organizations, academic institutes, and others.
Cyagen Biosciences, Charles River, Creative-Biolabs, TRANS GENIC INC.., Ltd., Sutter Instrument Company, Bio-Rad Laboratories, Inc., Spinco Biotech Pvt Ltd., Abbott, Thermo Fisher Scientific Inc., Sigma-Aldrich Co., Accumold, and others are some of the major players for transgenic animals market.